MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $39 avg across 3 analysts.
Buy-rated share 48% → 48% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $0.32 | $0.37 | +15.4% |
| Apr 2026 | $0.40 | $0.48 | +21.2% |
| Jan 2026 | $0.36 | $0.39 | +6.9% |
| Oct 2025 | $0.29 | $0.29 | -1.0% |
| Jul 2025 | $0.28 | $0.28 | +0.1% |
| Apr 2025 | $0.36 | $0.34 | -4.3% |
| Jan 2025 | $0.34 | $0.32 | -4.6% |
| Oct 2024 | $0.27 | $0.25 | -7.4% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$1.5M over 180 days (0 open-market buys, 11 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $17.5B— | $19.6B+11.5% | $15.2B-22.5% | $15.1B-0.5% | $16.9B+12.5% |
| EPS (dil.) | $0.78— | $1.12+43.6% | $1.06-5.4% | $1.17+10.4% | $1.37+17.1% |
| Free Cash Flow | $4.4B— | $3.3B-24.4% | $4.1B+23.9% | $3.0B-27.5% | $3.2B+7.2% |
| Gross Margin | 36.3% | 28.1%-8.2pp | 33.9%+5.7pp | 36.7%+2.8pp | 43.7%+7.0pp |
| Operating Margin | 30.1% | 22.6%-7.5pp | 26.7%+4.1pp | 29.1%+2.4pp | 28.4%-0.7pp |
| Net Margin | 10.2% | 13.0%+2.9pp | 15.8%+2.7pp | 17.3%+1.6pp | 18.0%+0.7pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 4.3%/yr (revenue basis).
Base free cash flow $3.5B (avg FY2023–FY2025; latest year $3.2B) · equity value $70.7B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 51 for KMI indicates a neutral outlook, driven by moderate scores across most factor categories. The stock scores relatively high on Risk, with a low beta of 0.6, but is dragged down by mediocre scores in Value, Growth, Momentum, and Profitability. Notably, KMI's P/E of 20.3 and EV/EBITDA of 12.8 suggest it trades at a premium, while its ROE near 11% and revenue growth of 12.5% exhibit some strength, though momentum has slowed with a -3.3% return over the past three months.